| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6068156 | The Journal of Allergy and Clinical Immunology: In Practice | 2016 | 7 Pages |
Abstract
Ceftaroline is used to treat a range of infections beyond SSTI and CAP. We observed a high rate of ADRs from ceftaroline, including signs of severe HSRs. More data are needed to understand the frequency and predictors of ceftaroline ADRs and HSRs.
Keywords
MGHallergy/immunologyBWHCeftarolineSSTIADRIQRHSRAllergyMRSAmethicillin-resistant Staphylococcus aureusBeta-lactamBrigham and Women's HospitalMassachusetts General HospitalHypersensitivityDrugAdverse drug reactionInfectious diseaseSkin and soft tissue infectioninterquartile rangeHypersensitivity reaction
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kimberly G. MD, James L. MD, Ana A. MD, MPH, Christy A. PharmD, David W. PharmD, Aleena MD, Erica S. MD, PhD,